* Sanara Medtech Inc SMTI.OQ SMTI.O is expected
to report
results on March 30.
* The Fort Worth Texas-based company is expected to report
revenue of $6.1 million, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sanara Medtech Inc
is for
a loss of 27 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $45, above its last closing price of $28.07.
This summary was machine generated March 28 at 20:57 GMT. All
figures in US dollars unless otherwise stated